First Page | Document Content | |
---|---|---|
Oncology Phosphoinositide 3-kinase AKT PTEN HER2/neu Breast cancer Akt/PKB signaling pathway Phosphoinositide-dependent kinase-1 Medicine Biology Protein kinases | Abstract 928 AACR 2012 The novel clinical candidate AT13148 is an oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity and a mechanism of action distinct from AKT inhibitorsAdd to Reading ListSource URL: astx.comDownload Document from Source WebsiteFile Size: 1,21 MBShare Document on Facebook |